Research Article Details
| Article ID: | A43477 | 
| PMID: | 31611037 | 
| Source: | Lancet HIV | 
| Title: | Tesamorelin, liver fat, and NAFLD in the setting of HIV. | 
| Abstract: | |
| DOI: | 10.1016/S2352-3018(19)30331-5 | 

| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs | 
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name | 
|---|
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| D160 | Growth Hormone | Biological drug | DB00052 | GHR ligand; PRLR ligand | -- | Under clinical trials | Details | 
| D363 | Tesamorelin | Chemical drug | DB08869 | GHRHR agonist;GHRHR binder | Growth stimulant | Under clinical trials | Details | 
| D316 | S-adenosyl-L-methionine | Chemical drug | DB00118 | GNMT cofactor | Antiviral | Under clinical trials | Details | 
| D343 | Somatropin | Biological drug | DB00052 | GHR ligand; PRLR ligand | Hormone replacement drug | Under clinical trials | Details |